
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 718635-93-9 | 货号 | BCP24156 |
中文名 | Tetrabenazine | ||
英文名 | Tetrabenazine | ||
中文别名 | |||
英文别名 | Ro 1-9569; | ||
SMILES | |||
化学名称 | |||
分子式 | C19H27NO3 | 分子量 | 317.42 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | The vesicular monoamine transporter type 2 (VMAT2) inhibitors are agents that cause a depletion of neuroactive peptides such as dopamine in nerve terminals and are used to treat chorea due to neurodegenerative diseases (such as Huntington chorea) or dyskinesias due to neuroleptic medications (tardive dyskinesia). As of 2019, three VMAT2 inhibitors have become available in the United States for management of dyskinesia syndromes, each with a somewhat different spectrum of approved indications: tetrabenazine (Xenazine and generics: 2008), deutetrabenazine (Austedo: 2017) and valbenazine (Ingressa: 2017). The VMAT2 inihibitors have not been associated with serum enzyme elevations during therapy or linked to instances of clinically apparent liver injury, but they have had limited general clinical use. |
相关产品推荐
查看更多 >Tags:Tetrabenazine 供应商,Tetrabenazine 购买,Tetrabenazine 生产,Tetrabenazine 批量,Tetrabenazine 供应,Tetrabenazine 订购,Tetrabenazine 采购